Tech Company Financing Transactions
MentiNova Funding Round
MentiNova, operating out of Princeton, received $500 thousand in investment from Foundation Venture Capital Group.
Transaction Overview
Company Name
Announced On
1/29/2013
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Foundation Venture Capital Group (James Golubieski)
Proceeds Purpose
According to James M. Golubieski, president of FVCG, the investment in MentiNova will allow the company to advance the status of its IND (Investigational New Drug) filing with the FDA and to perform clinical trials testing the efficacy of the treatment.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
155 Village Blvd. 130
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Undisclosed
Website
Email Address
Overview
The company is exploring an oral medication that could reduce these uncontrollable, often chaotic movements in patients being treated with L-Dopa.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Steven Braithwaite
President
Maral Mouradian
Browse more venture capital transactions:
Prev: 1/29/2013: DataGravity venture capital transaction
Next: 1/29/2013: N-Trig venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on every notable VC transaction. VC transactions on this site are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs